| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 123, 1962-1969, Copyright © 1988 by Endocrine Society
ARTICLES |
S Tsagarakis, JM Holly, LH Rees, GM Besser and A Grossman
Department of Endocrinology, St Bartholomew's Hospital, London, United Kingdom.
The effects of the two putative neurotransmitters acetylcholine and norepinephrine on immunoreactive CRF-41 release from incubated rat hypothalami were studied. Acetylcholine at concentrations of 10(-11) to 10(-7) M stimulated CRF-41 release. This effect was blocked in a dose- dependent manner by the muscarinic antagonist atropine (10(-9) to (-7) M). The nicotinic antagonist hexamethonium was ineffective at a dose of 10(-7) M, but produced slight inhibition of this response at 10(-5) M. Norepinephrine at concentrations of 10(-10) to 10(-6) M also produced a dose-dependent stimulation of CRF-41 release. The beta-adrenoceptor antagonists propranolol (10(-5) M) and timolol (10(-6) M) blocked norepinephrine-induced CRF-41 release. The alpha 1-adrenoceptor antagonists thymoxamine (10(-5) M), prazosin (10(-5) M), and corynanthine (10(-4) M), and the alpha 2-antagonist idazoxan (10(-5) M), were ineffective. Potassium depolarization (56 mM) caused stimulation of CRF-41 release which was dependent on the presence of calcium in the incubation medium. Authenticity of immunoreactive CRF-41 released was demonstrated by chromatographic criteria using gel filtration and reversed phase HPLC. These results provide evidence for a stimulatory role of acetylcholine and norepinephrine on CRF-41 release, and consequently on hypothalamo-pituitary-adrenal axis in the rat, through actions at a hypothalamic level. The stimulatory effect of acetylcholine is mediated principally through muscarinic receptors and that of norepinephrine through beta-adrenoceptors.
This article has been cited by other articles:
![]() |
B. A S Reyes, H. Tsukamura, H. I'Anson, M. A. C Estacio, K. Hirunagi, and K.-I. Maeda Temporal expression of estrogen receptor {alpha} in the hypothalamus and medulla oblongata during fasting: a role of noradrenergic neurons. J. Endocrinol., September 1, 2006; 190(3): 593 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Leri, J. Flores, D. Rodaros, and J. Stewart Blockade of Stress-Induced But Not Cocaine-Induced Reinstatement by Infusion of Noradrenergic Antagonists into the Bed Nucleus of the Stria Terminalis or the Central Nucleus of the Amygdala J. Neurosci., July 1, 2002; 22(13): 5713 - 5718. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Castro, R. Peñalva, M. P. Pereda, U. Renner, J. M. H. M. Reul, G. K. Stalla, F. Holsboer, and E. Arzt Early Activation of Thyrotropin-Releasing-Hormone and Prolactin Plays a Critical Role during a T Cell-Dependent Immune Response Endocrinology, February 1, 1999; 140(2): 690 - 697. [Abstract] [Full Text] |
||||
![]() |
Y. Fu, S. G. Matta, J. D. Valentine, and B. M. Sharp Adrenocorticotropin Response and Nicotine-Induced Norepinephrine Secretion in the Rat Paraventricular Nucleus Are Mediated through Brainstem Receptors Endocrinology, May 1, 1997; 138(5): 1935 - 1943. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |